GI clinical research 2002-2003: the year in review.
Camilleri
Michael
M
Mayo Clinic, Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Rochester, MN 55905, USA. camilleri.michael@mayo.edu
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D035843:Biomedical Research; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000628:therapy; D005767:Gastrointestinal Diseases / Q000453:epidemiology / Q000628:therapy*; D019694:Hepatitis B, Chronic / Q000453:epidemiology / Q000628:therapy; D019698:Hepatitis C, Chronic / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D000068877:Imatinib Mesylate; D043183:Irritable Bowel Syndrome / Q000453:epidemiology / Q000628:therapy; D010438:Peptic Ulcer Hemorrhage / Q000453:epidemiology / Q000628:therapy; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000628:therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate